Aggressive Posterior Retinopathy of Prematurity and a TUBA1A Mutation in de Morsier Syndrome

被引:3
|
作者
Reyes-Capo, Daniela P. [1 ]
Chen, Felix [1 ]
Wilson, Benjamin [1 ]
Tarshish, Brocha [2 ]
Ventura, Camila V. [3 ]
Read, Sarah P. [3 ]
Negron, Catherin, I [3 ]
Berrocal, Audina M. [3 ]
机构
[1] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[2] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Dept Human Genet, Miami, FL 33136 USA
[3] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA
来源
关键词
PERIPHERAL RETINAL NONPERFUSION; OPTIC-NERVE HYPOPLASIA;
D O I
10.3928/23258160-20180803-12
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The authors report a case of a premature male neonate born at 25.3 weeks gestational age weighing 605 grams with septo-optic dysplasia (SOD) and a heterozygous mutation in TUBA1A c.715A>C, a critical gene for microtubules, who developed asymmetric and aggressive posterior retinopathy of prematurity (ROP). This report presents a novel mutation associated with SOD and proposes that optic nerve hypoplasia may have potentiated a severe ROP phenotype.
引用
收藏
页码:629 / 632
页数:4
相关论文
共 50 条
  • [1] Case of shapiro syndrome in a pediatric patient with TUBA1A gene mutation
    Ermekbaeva, A.
    Slattery, J.
    Azam, A.
    Iheagwara, K.
    Shah, Y.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2024, 367 : S445 - S446
  • [2] DTI tractography of lissencephaly caused by TUBA1A mutation
    Kamiya, Kouhei
    Tanaka, Fumine
    Ikeno, Mitsuru
    Okumura, Akihisa
    Aoki, Shigeki
    NEUROLOGICAL SCIENCES, 2014, 35 (05) : 801 - 803
  • [3] DTI tractography of lissencephaly caused by TUBA1A mutation
    Kouhei Kamiya
    Fumine Tanaka
    Mitsuru Ikeno
    Akihisa Okumura
    Shigeki Aoki
    Neurological Sciences, 2014, 35 : 801 - 803
  • [4] The results of intravitreal bevacizumab monotherapy for treating aggressive posterior retinopathy of prematurity and Type 1 retinopathy of prematurity
    Comez, Aysegul
    Karakucuk, Yalcin
    Ozmen, Mehmet Cuneyt
    Celemler, Pelin
    Saygili, Oguzhan
    EYE, 2021, 35 (12) : 3302 - 3310
  • [5] Bevacizumab or laser for aggressive posterior retinopathy of prematurity
    Blair, Michael
    Gonzalez, Jose Maria Garcia
    Snyder, Laura
    Schechet, Sidney
    Greenwald, Mark
    Shapiro, Michael
    Rodriguez, Sarah Hilkert
    TAIWAN JOURNAL OF OPHTHALMOLOGY, 2018, 8 (04) : 243 - 248
  • [6] Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity
    Li, Xiu-Juan
    Yang, Xiao-Peng
    Sun, Shuang
    Lyu, Xiao-Bei
    Jia, Heng
    CHINESE MEDICAL JOURNAL, 2016, 129 (23) : 2879 - 2881
  • [7] Macular Development in Aggressive Posterior Retinopathy of Prematurity
    Pandya, Hemang K.
    Faia, Lisa J.
    Robinson, Joshua
    Drenser, Kimberly A.
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [8] The results of intravitreal bevacizumab monotherapy for treating aggressive posterior retinopathy of prematurity and Type 1 retinopathy of prematurity
    Ayşegül Çömez
    Yalçın Karaküçük
    Mehmet Cüneyt Özmen
    Pelin Çelemler
    Oğuzhan Saygılı
    Eye, 2021, 35 : 3302 - 3310
  • [9] Aggressive-posterior retinopathy of prematurity (ROP)
    Quinn, GE
    Ells, AL
    Fielder, A
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [10] Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity
    Xiu-Juan Li
    Xiao-Peng Yang
    Shuang Sun
    Xiao-Bei Lyu
    Heng Jia
    中华医学杂志英文版, 2016, 129 (23) : 2879 - 2881